ProfileGDS5678 / 1423049_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 111.069699
GSM967853U87-EV human glioblastoma xenograft - Control 211.596399
GSM967854U87-EV human glioblastoma xenograft - Control 311.76999
GSM967855U87-EV human glioblastoma xenograft - Control 410.945799
GSM967856U87-EV human glioblastoma xenograft - Control 511.300299
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 111.156499
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 211.146599
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 311.180299
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.892499
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.807199
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 210.849599
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.011299
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 411.240499
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.961999